Search Results - "Garcia‐Compean, Diego"

Refine Results
  1. 1

    Liver cirrhosis and diabetes: Risk factors, pathophysiology, clinical implications and management by Diego Garcia-Compean Joel Omar Jaquez-Quintana Jose Alberto Gonzalez-Gonzalez Hector Maldonado-Garza

    Published in World journal of gastroenterology : WJG (21-01-2009)
    “…About 30% of patients with cirrhosis have diabetes mellitus (DM). Nowadays, it is a matter for debate whether type 2 DM in the absence of obesity and…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Hepatogenous diabetes: Is it a neglected condition in chronic liver disease? by Diego García-Compeán José Alberto González-González Fernando Javier Lavalle-González Emmanuel Irineo González-Moreno Jesús Zacarías Villarreal-Pérez Héctor Jesús Maldonado-Garza

    Published in World journal of gastroenterology : WJG (14-03-2016)
    “…Diabetes mellitus(DM) that occurs because of chronic liver disease(CLD) is known as hepatogenous diabetes(HD). Although the association of diabetes and liver…”
    Get full text
    Journal Article
  4. 4

    The treatment of diabetes mellitus of patients with chronic liver disease by García-Compeán, Diego, González-González, José A, Lavalle-González, Fernando J, González-Moreno, Emmanuel I, Maldonado-Garza, Héctor J, Villarreal-Pérez, Jesús Z

    Published in Annals of hepatology (01-11-2015)
    “…AbstractAbout 80% of patients with liver cirrhosis may have glucose metabolism disorders, 30% show overt diabetes mellitus (DM). Prospective studies have…”
    Get full text
    Journal Article
  5. 5

    Hepatogenous diabetes. Current views of an ancient problem by García-Compean, Diego, Jaquez-Quintana, Joel Omar, Maldonado-Garza, Héctor

    Published in Annals of hepatology (01-01-2009)
    “…Diabetes developed as a complication of cirrhosis is known as hepatogenous diabetes>> (HD). Around 30% to 60% of cirrhotic patients suffer from this metabolic…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    Intragastric injection of botulinum toxin for the treatment of obesity. Where are we by Garcia-Compean, Diego, Maldonado Garza, Hector

    Published in World journal of gastroenterology : WJG (28-03-2008)
    “…Obesity has reached epidemic proportions particularly in western countries. Most non-surgical treatments of this condition are disappointing. Since 2005,…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Plasma cytokine levels imbalance in cirrhotic patients with impaired glucose tolerance and diabetes mellitus. A prospective study by García-Compeán, Diego, M.D., M.MSc, Jáquez-Quintana, Joel O, Lavalle-González, Fernando J, González-González, José A, Maldonado-Garza, Héctor J, Villarreal-Pérez, Jesús Z

    Published in Annals of hepatology (01-07-2014)
    “…AbstractAims. To define if there is an imbalance in plasma levels of proinflammatory, fibrogenic and antifibrogenic cytokines in patients with liver cirrhosis…”
    Get full text
    Journal Article
  12. 12

    Diagnostic and therapeutic challenges of gastrointestinal angiodysplasias: A critical review and view points by García-Compeán, Diego, Del Cueto-Aguilera, Ángel N, Jiménez-Rodríguez, Alan R, González-González, José A, Maldonado-Garza, Héctor J

    Published in World journal of gastroenterology : WJG (07-06-2019)
    “…Gastrointestinal angiodysplasias (GIADs), also called angioectasias, are the most frequent vascular lesions. Its precise prevalence is unknown since most of…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Post-acute pancreatitis diabetes: A complication waiting for more recognition and understanding by García-Compeán, Diego, Jiménez-Rodríguez, Alan R, Muñoz-Ayala, Juan M, González-González, José A, Maldonado-Garza, Héctor J, Villarreal-Pérez, Jesús Z

    Published in World journal of gastroenterology : WJG (28-07-2023)
    “…Post-acute pancreatitis diabetes (PAPD) is the second most common type of diabetes below type 2 diabetes mellitus. Due to the boom in research on this entity…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Model for end stage of liver disease (MELD) is better than the Child-Pugh score for predicting in-hospital mortality related to esophageal variceal bleeding by Flores-Rendón, Angel Ricardo, González-González, José Alberto, García-Compean, Diego, Maldonado-Garza, Héctor Jesús, Garza-Galindo, Aldo Azael

    Published in Annals of hepatology (01-07-2008)
    “…The Child Pugh and MELD are good methods for predicting mortality in patients with chronic liver disease. We investigated their performance as risk factors for…”
    Get full text
    Journal Article
  18. 18

    Current Concepts in Diabetes Mellitus and Chronic Liver Disease: Clinical Outcomes, Hepatitis C Virus Association, and Therapy by García-Compeán, Diego, González-González, José Alberto, Lavalle-González, Fernando Javier, González-Moreno, Emmanuel Irineo, Villarreal-Pérez, Jesús Zacarías, Maldonado-Garza, Héctor J.

    Published in Digestive diseases and sciences (01-02-2016)
    “…Hereditary type 2 diabetes mellitus is a risk factor for chronic liver disease, and ~30 % of patients with liver cirrhosis develop diabetes. Diabetes mellitus…”
    Get full text
    Journal Article Book Review
  19. 19
  20. 20

    Low Prevalence of Biopsy-Proven Eosinophilic Esophagitis in Patients with Esophageal Food Impaction in Mexican Population by García-Compeán, Diego, González-González, José A, Duran-Castro, José J, Herrera-Quiñones, Gilberto, Borjas-Almaguer, Omar D, Maldonado-Garza, Héctor J

    Published in Digestive diseases and sciences (01-06-2018)
    “…Background Eosinophilic esophagitis (EoE) is the most common cause of dysphagia and esophageal food impaction (EFI) in the USA, Western Europe, and Australia…”
    Get full text
    Journal Article